Skip to main content
Mitchell Felder, MD, Neurology, Marshfield, WI

Mitchell S Felder MD


Physician

Join to View Full Profile
  • 1000 N Oak AveMarshfield, WI 54449

  • Phone+1 715-387-5511

Dr. Felder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Westchester Medical Center
    Westchester Medical CenterResidency, Neurology, 1985 - 1988
  • Hackensack University Medical Center/Englewood Hospital and Medical Center
    Hackensack University Medical Center/Englewood Hospital and Medical CenterInternship, Internal Medicine, 1984 - 1985
  • Sapienza University of Rome
    Sapienza University of RomeClass of 1983

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2005 - 2027
  • PA State Medical License
    PA State Medical License 1988 - 2026
  • SC State Medical License
    SC State Medical License 2016 - 2025
  • WI State Medical License
    WI State Medical License 2019 - 2025
  • MT State Medical License
    MT State Medical License 2018 - 2022
  • NM State Medical License
    NM State Medical License 2018 - 2022
  • NJ State Medical License
    NJ State Medical License 1985 - 1989
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Press Mentions

  • Halberd Corporation Advisory Board Reorganization Announced
    Halberd Corporation Advisory Board Reorganization AnnouncedDecember 1st, 2020
  • Premier Biomedical Signs Joint Venture Agreement with New Earth Development, RushNet Inc., and XYZ Hemp, Inc. To Market New Anti-Addiction Patch
    Premier Biomedical Signs Joint Venture Agreement with New Earth Development, RushNet Inc., and XYZ Hemp, Inc. To Market New Anti-Addiction PatchJuly 30th, 2019
  • Premier Biomedical's Research on Its Patent Pending Anti-Cancer Treatment with Metronomic Chemotherapy Recognized for Publication in the Prestigious British Journal of Cancer
    Premier Biomedical's Research on Its Patent Pending Anti-Cancer Treatment with Metronomic Chemotherapy Recognized for Publication in the Prestigious British Journal of CancerDecember 6th, 2016

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: